These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25473896)

  • 1. HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.
    Conte M; Dell'Aversana C; Benedetti R; Petraglia F; Carissimo A; Petrizzi VB; D'Arco AM; Abbondanza C; Nebbioso A; Altucci L
    Oncotarget; 2015 Jan; 6(2):886-901. PubMed ID: 25473896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of HDAC2 in Spinal Cord Alleviates Mechanical Hyperalgesia and Restores KCC2 Expression in a Rat Model of Bone Cancer Pain.
    Hou X; Weng Y; Wang T; Ouyang B; Li Y; Song Z; Pan Y; Zhang Z; Zou W; Huang C; Guo Q
    Neuroscience; 2018 May; 377():138-149. PubMed ID: 29482000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.
    Kim JK; Noh JH; Eun JW; Jung KH; Bae HJ; Shen Q; Kim MG; Chang YG; Kim SJ; Park WS; Lee JY; Borlak J; Nam SW
    Mol Cancer Res; 2013 Jan; 11(1):62-73. PubMed ID: 23175521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
    Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
    Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke.
    Tang Y; Lin YH; Ni HY; Dong J; Yuan HJ; Zhang Y; Liang HY; Yao MC; Zhou QG; Wu HY; Chang L; Luo CX; Zhu DY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis.
    Zimberlin CD; Lancini C; Sno R; Rosekrans SL; McLean CM; Vlaming H; van den Brink GR; Bots M; Medema JP; Dannenberg JH
    FASEB J; 2015 May; 29(5):2070-80. PubMed ID: 25648995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-mediated deacetylation of the ribonuclease 1 promoter
    Bedenbender K; Scheller N; Fischer S; Leiting S; Preissner KT; Schmeck BT; Vollmeister E
    FASEB J; 2019 Aug; 33(8):9017-9029. PubMed ID: 31039328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Pulmonary Fibrosis via Trichostatin A (TSA) in Bleomycin Induced Rats.
    Ye Q; Li Y; Jiang H; Xiong J; Xu J; Qin H; Liu B
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):219-26. PubMed ID: 25363222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.
    Gameiro SR; Malamas AS; Tsang KY; Ferrone S; Hodge JW
    Oncotarget; 2016 Feb; 7(7):7390-402. PubMed ID: 26862729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.
    Qian Y; Jung YS; Chen X
    J Biol Chem; 2011 Apr; 286(14):12033-41. PubMed ID: 21317427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
    Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
    Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.
    Kurita M; Holloway T; García-Bea A; Kozlenkov A; Friedman AK; Moreno JL; Heshmati M; Golden SA; Kennedy PJ; Takahashi N; Dietz DM; Mocci G; Gabilondo AM; Hanks J; Umali A; Callado LF; Gallitano AL; Neve RL; Shen L; Buxbaum JD; Han MH; Nestler EJ; Meana JJ; Russo SJ; González-Maeso J
    Nat Neurosci; 2012 Sep; 15(9):1245-54. PubMed ID: 22864611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
    de la Fuente Revenga M; Ibi D; Saunders JM; Cuddy T; Ijaz MK; Toneatti R; Kurita M; Holloway T; Shen L; Seto J; Dozmorov MG; González-Maeso J
    Neuroscience; 2018 Sep; 388():102-117. PubMed ID: 30025863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.
    Björkman M; Iljin K; Halonen P; Sara H; Kaivanto E; Nees M; Kallioniemi OP
    Int J Cancer; 2008 Dec; 123(12):2774-81. PubMed ID: 18798265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
    Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
    J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192.
    Boissinot M; Inman M; Hempshall A; James SR; Gill JH; Selby P; Bowen DT; Grigg R; Cockerill PN
    Leuk Res; 2012 Oct; 36(10):1304-10. PubMed ID: 22818799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.